Microsphere Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-09

Pages: 138 Pages

Report ld: 6070492

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Microsphere Injection was estimated to be worth US$ 209 million in 2025 and is projected to reach US$ 302 million, growing at a CAGR of 5.5% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Microsphere Injection cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Microsphere Injection Market Size(US$)

M= millions and B=billions

Microsphere Injection are tiny, spherical particles—typically ranging from a few micrometers to a few hundred micrometers in diameter—designed to be delivered into the body via injection for therapeutic or diagnostic purposes. Made from biocompatible materials such as polymers (e.g., PLGA, gelatin) or ceramics, these microspheres can encapsulate drugs, proteins, or imaging agents, allowing for controlled release, targeted delivery, and reduced side effects. They are widely used in drug delivery systems, cancer therapy, tissue engineering, and cosmetic or aesthetic treatments (like dermal fillers). Their customizable size, composition, and release pr
The North American market for Microsphere Injection was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Microsphere Injection was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Microsphere Injection was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Microsphere Injection market include Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Microsphere Injection, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Microsphere Injection market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Microsphere Injection.

Market Segmentation

Report Metric
Details
Report Title
Microsphere Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 302 million
CAGR(2026-2032)
5.5%
Market Size Available for Years
2026-2032
Global Microsphere Injection Companies Covered
Novartis
Ferring
Ipsen
Takeda
Roche
AstraZeneca
OraPharma
Alkermes
Pacira BioSciences
Xian Janssen Pharmaceutical
Shandong Luye Pharmaceutical
Livzon Pharmaceutical
Zhejiang Sundoc Pharmaceutical Science and Tech
Beijing Boente Pharmaceutical
Guangzhou DiQi Pharmaceuticals
Qilu Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui BBCA Biochemical
Yichang Humanwell Pharmaceutical
Global Microsphere Injection Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Microsphere Injection Market, Segment by Type
Risperidone Microspheres
Leuprorelin Microspheres
Octreotide Microspheres
Triptorelin Microspheres
Others
Global Microsphere Injection Market, Segment by Application
Malignant Tumors
Diabetes
Cardiovascular Diseases
Mental Illness
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Microsphere Injection manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Microsphere Injection sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Microsphere Injection sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Microsphere Injection Product Introduction
    1.2 Global Microsphere Injection Market Size Forecast
        1.2.1 Global Microsphere Injection Sales Value (2021–2032)
        1.2.2 Global Microsphere Injection Sales Volume (2021–2032)
        1.2.3 Global Microsphere Injection Sales Price (2021–2032)
    1.3 Microsphere Injection Market Trends & Drivers
        1.3.1 Microsphere Injection Industry Trends
        1.3.2 Microsphere Injection Market Drivers & Opportunities
        1.3.3 Microsphere Injection Market Challenges
        1.3.4 Microsphere Injection Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Microsphere Injection Players Revenue Ranking (2025)
    2.2 Global Microsphere Injection Revenue by Company (2021–2026)
    2.3 Global Microsphere Injection Sales Volume Ranking of Players (2025)
    2.4 Global Microsphere Injection Sales Volume by Company (2021–2026)
    2.5 Global Microsphere Injection Average Price by Company (2021–2026)
    2.6 Key Manufacturers Microsphere Injection Manufacturing Base and Headquarters
    2.7 Key Manufacturers Microsphere Injection Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Microsphere Injection
    2.9 Microsphere Injection Market Competitive Analysis
        2.9.1 Microsphere Injection Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Microsphere Injection Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Microsphere Injection revenue, 2025
    2.10 Mergers & Acquisitions and Expansion

3 Segmentation Microsphere Injection Market Classification
    3.1 Introduction by Type
        3.1.1 Risperidone Microspheres
        3.1.2 Leuprorelin Microspheres
        3.1.3 Octreotide Microspheres
        3.1.4 Triptorelin Microspheres
        3.1.5 Others
        3.1.6 Global Microsphere Injection Sales Value by Type
            3.1.6.1 Global Microsphere Injection Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.6.2 Global Microsphere Injection Sales Value, by Type (2021–2032)
            3.1.6.3 Global Microsphere Injection Sales Value, by Type (%), 2021–2032
        3.1.7 Global Microsphere Injection Sales Volume by Type
            3.1.7.1 Global Microsphere Injection Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.7.2 Global Microsphere Injection Sales Volume, by Type (2021–2032)
            3.1.7.3 Global Microsphere Injection Sales Volume, by Type (%), 2021–2032
        3.1.8 Global Microsphere Injection Average Price by Type (2021–2032)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Malignant Tumors
        4.1.2 Diabetes
        4.1.3 Cardiovascular Diseases
        4.1.4 Mental Illness
        4.1.5 Others
    4.2 Global Microsphere Injection Sales Value by Application
        4.2.1 Global Microsphere Injection Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Microsphere Injection Sales Value, by Application (2021–2032)
        4.2.3 Global Microsphere Injection Sales Value, by Application (%), 2021–2032
    4.3 Global Microsphere Injection Sales Volume by Application
        4.3.1 Global Microsphere Injection Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global Microsphere Injection Sales Volume, by Application (2021–2032)
        4.3.3 Global Microsphere Injection Sales Volume, by Application (%), 2021–2032
    4.4 Global Microsphere Injection Average Price by Application (2021–2032)

5 Segmentation by Region
    5.1 Global Microsphere Injection Sales Value by Region
        5.1.1 Global Microsphere Injection Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Microsphere Injection Sales Value by Region (2021–2026)
        5.1.3 Global Microsphere Injection Sales Value by Region (2027–2032)
        5.1.4 Global Microsphere Injection Sales Value by Region (%), 2021–2032
    5.2 Global Microsphere Injection Sales Volume by Region
        5.2.1 Global Microsphere Injection Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Microsphere Injection Sales Volume by Region (2021–2026)
        5.2.3 Global Microsphere Injection Sales Volume by Region (2027–2032)
        5.2.4 Global Microsphere Injection Sales Volume by Region (%), 2021–2032
    5.3 Global Microsphere Injection Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Microsphere Injection Sales Value, 2021–2032
        5.4.2 North America Microsphere Injection Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Microsphere Injection Sales Value, 2021–2032
        5.5.2 Europe Microsphere Injection Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Microsphere Injection Sales Value, 2021–2032
        5.6.2 Asia Pacific Microsphere Injection Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Microsphere Injection Sales Value, 2021–2032
        5.7.2 South America Microsphere Injection Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Microsphere Injection Sales Value, 2021–2032
        5.8.2 Middle East & Africa Microsphere Injection Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Microsphere Injection Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Microsphere Injection Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Microsphere Injection Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Microsphere Injection Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Microsphere Injection Sales Value, 2021–2032
        6.3.2 United States Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Microsphere Injection Sales Value, 2021–2032
        6.4.2 Europe Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Microsphere Injection Sales Value, 2021–2032
        6.5.2 China Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Microsphere Injection Sales Value, 2021–2032
        6.6.2 Japan Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Microsphere Injection Sales Value, 2021–2032
        6.7.2 South Korea Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Microsphere Injection Sales Value, 2021–2032
        6.8.2 Southeast Asia Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Microsphere Injection Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Microsphere Injection Sales Value, 2021–2032
        6.9.2 India Microsphere Injection Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Microsphere Injection Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Company Information
        7.1.2 Novartis Introduction and Business Overview
        7.1.3 Novartis Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Novartis Microsphere Injection Product Offerings
        7.1.5 Novartis Recent Developments
    7.2 Ferring
        7.2.1 Ferring Company Information
        7.2.2 Ferring Introduction and Business Overview
        7.2.3 Ferring Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 Ferring Microsphere Injection Product Offerings
        7.2.5 Ferring Recent Developments
    7.3 Ipsen
        7.3.1 Ipsen Company Information
        7.3.2 Ipsen Introduction and Business Overview
        7.3.3 Ipsen Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 Ipsen Microsphere Injection Product Offerings
        7.3.5 Ipsen Recent Developments
    7.4 Takeda
        7.4.1 Takeda Company Information
        7.4.2 Takeda Introduction and Business Overview
        7.4.3 Takeda Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 Takeda Microsphere Injection Product Offerings
        7.4.5 Takeda Recent Developments
    7.5 Roche
        7.5.1 Roche Company Information
        7.5.2 Roche Introduction and Business Overview
        7.5.3 Roche Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 Roche Microsphere Injection Product Offerings
        7.5.5 Roche Recent Developments
    7.6 AstraZeneca
        7.6.1 AstraZeneca Company Information
        7.6.2 AstraZeneca Introduction and Business Overview
        7.6.3 AstraZeneca Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 AstraZeneca Microsphere Injection Product Offerings
        7.6.5 AstraZeneca Recent Developments
    7.7 OraPharma
        7.7.1 OraPharma Company Information
        7.7.2 OraPharma Introduction and Business Overview
        7.7.3 OraPharma Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 OraPharma Microsphere Injection Product Offerings
        7.7.5 OraPharma Recent Developments
    7.8 Alkermes
        7.8.1 Alkermes Company Information
        7.8.2 Alkermes Introduction and Business Overview
        7.8.3 Alkermes Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 Alkermes Microsphere Injection Product Offerings
        7.8.5 Alkermes Recent Developments
    7.9 Pacira BioSciences
        7.9.1 Pacira BioSciences Company Information
        7.9.2 Pacira BioSciences Introduction and Business Overview
        7.9.3 Pacira BioSciences Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 Pacira BioSciences Microsphere Injection Product Offerings
        7.9.5 Pacira BioSciences Recent Developments
    7.10 Xian Janssen Pharmaceutical
        7.10.1 Xian Janssen Pharmaceutical Company Information
        7.10.2 Xian Janssen Pharmaceutical Introduction and Business Overview
        7.10.3 Xian Janssen Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 Xian Janssen Pharmaceutical Microsphere Injection Product Offerings
        7.10.5 Xian Janssen Pharmaceutical Recent Developments
    7.11 Shandong Luye Pharmaceutical
        7.11.1 Shandong Luye Pharmaceutical Company Information
        7.11.2 Shandong Luye Pharmaceutical Introduction and Business Overview
        7.11.3 Shandong Luye Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.11.4 Shandong Luye Pharmaceutical Microsphere Injection Product Offerings
        7.11.5 Shandong Luye Pharmaceutical Recent Developments
    7.12 Livzon Pharmaceutical
        7.12.1 Livzon Pharmaceutical Company Information
        7.12.2 Livzon Pharmaceutical Introduction and Business Overview
        7.12.3 Livzon Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.12.4 Livzon Pharmaceutical Microsphere Injection Product Offerings
        7.12.5 Livzon Pharmaceutical Recent Developments
    7.13 Zhejiang Sundoc Pharmaceutical Science and Tech
        7.13.1 Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
        7.13.2 Zhejiang Sundoc Pharmaceutical Science and Tech Introduction and Business Overview
        7.13.3 Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.13.4 Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Product Offerings
        7.13.5 Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments
    7.14 Beijing Boente Pharmaceutical
        7.14.1 Beijing Boente Pharmaceutical Company Information
        7.14.2 Beijing Boente Pharmaceutical Introduction and Business Overview
        7.14.3 Beijing Boente Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.14.4 Beijing Boente Pharmaceutical Microsphere Injection Product Offerings
        7.14.5 Beijing Boente Pharmaceutical Recent Developments
    7.15 Guangzhou DiQi Pharmaceuticals
        7.15.1 Guangzhou DiQi Pharmaceuticals Company Information
        7.15.2 Guangzhou DiQi Pharmaceuticals Introduction and Business Overview
        7.15.3 Guangzhou DiQi Pharmaceuticals Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.15.4 Guangzhou DiQi Pharmaceuticals Microsphere Injection Product Offerings
        7.15.5 Guangzhou DiQi Pharmaceuticals Recent Developments
    7.16 Qilu Pharmaceutical
        7.16.1 Qilu Pharmaceutical Company Information
        7.16.2 Qilu Pharmaceutical Introduction and Business Overview
        7.16.3 Qilu Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.16.4 Qilu Pharmaceutical Microsphere Injection Product Offerings
        7.16.5 Qilu Pharmaceutical Recent Developments
    7.17 Changchun GeneScience Pharmaceutical
        7.17.1 Changchun GeneScience Pharmaceutical Company Information
        7.17.2 Changchun GeneScience Pharmaceutical Introduction and Business Overview
        7.17.3 Changchun GeneScience Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.17.4 Changchun GeneScience Pharmaceutical Microsphere Injection Product Offerings
        7.17.5 Changchun GeneScience Pharmaceutical Recent Developments
    7.18 Anhui BBCA Biochemical
        7.18.1 Anhui BBCA Biochemical Company Information
        7.18.2 Anhui BBCA Biochemical Introduction and Business Overview
        7.18.3 Anhui BBCA Biochemical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.18.4 Anhui BBCA Biochemical Microsphere Injection Product Offerings
        7.18.5 Anhui BBCA Biochemical Recent Developments
    7.19 Yichang Humanwell Pharmaceutical
        7.19.1 Yichang Humanwell Pharmaceutical Company Information
        7.19.2 Yichang Humanwell Pharmaceutical Introduction and Business Overview
        7.19.3 Yichang Humanwell Pharmaceutical Microsphere Injection Sales, Revenue, Price and Gross Margin (2021–2026)
        7.19.4 Yichang Humanwell Pharmaceutical Microsphere Injection Product Offerings
        7.19.5 Yichang Humanwell Pharmaceutical Recent Developments

8 Industry Chain Analysis
    8.1 Microsphere Injection Industrial Chain
    8.2 Microsphere Injection Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Microsphere Injection Sales Model
        8.5.2 Sales Channels
        8.5.3 Microsphere Injection Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Microsphere Injection Market Trends
 Table 2. Microsphere Injection Market Drivers & Opportunities
 Table 3. Microsphere Injection Market Challenges
 Table 4. Microsphere Injection Market Restraints
 Table 5. Global Microsphere Injection Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Microsphere Injection Revenue Market Share by Company (2021–2026)
 Table 7. Global Microsphere Injection Sales Volume by Company (K Units), 2021–2026
 Table 8. Global Microsphere Injection Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Microsphere Injection Price by Company (US$/Unit), 2021–2026
 Table 10. Key Manufacturers Microsphere Injection Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Microsphere Injection Product Type
 Table 12. Key Manufacturers Start of Mass Production of Microsphere Injection
 Table 13. Global Microsphere Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Microsphere Injection revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Microsphere Injection Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Microsphere Injection Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Microsphere Injection Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Microsphere Injection Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Microsphere Injection Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Microsphere Injection Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
 Table 22. Global Microsphere Injection Sales Volume by Type (K Units), 2021–2026
 Table 23. Global Microsphere Injection Sales Volume by Type (K Units), 2027–2032
 Table 24. Global Microsphere Injection Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Microsphere Injection Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Microsphere Injection Price by Type (US$/Unit), 2021–2026
 Table 27. Global Microsphere Injection Price by Type (US$/Unit), 2027–2032
 Table 28. Global Microsphere Injection Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Microsphere Injection Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Microsphere Injection Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Microsphere Injection Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Microsphere Injection Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Microsphere Injection Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
 Table 34. Global Microsphere Injection Sales Volume by Application (K Units), 2021–2026
 Table 35. Global Microsphere Injection Sales Volume by Application (K Units), 2027–2032
 Table 36. Global Microsphere Injection Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Microsphere Injection Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Microsphere Injection Price by Application (US$/Unit), 2021–2026
 Table 39. Global Microsphere Injection Price by Application (US$/Unit), 2027–2032
 Table 40. Global Microsphere Injection Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Microsphere Injection Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Microsphere Injection Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Microsphere Injection Sales Value by Region (%), 2021–2026
 Table 44. Global Microsphere Injection Sales Value by Region (%), 2027–2032
 Table 45. Global Microsphere Injection Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
 Table 46. Global Microsphere Injection Sales Volume by Region (K Units), 2021–2026
 Table 47. Global Microsphere Injection Sales Volume by Region (K Units), 2027–2032
 Table 48. Global Microsphere Injection Sales Volume by Region (%), 2021–2026
 Table 49. Global Microsphere Injection Sales Volume by Region (%), 2027–2032
 Table 50. Global Microsphere Injection Average Price by Region (US$/Unit), 2021–2026
 Table 51. Global Microsphere Injection Average Price by Region (US$/Unit), 2027–2032
 Table 52. Key Countries/Regions Microsphere Injection Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Microsphere Injection Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Microsphere Injection Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Microsphere Injection Sales Volume, (K Units), 2021–2026
 Table 56. Key Countries/Regions Microsphere Injection Sales Volume, (K Units), 2027–2032
 Table 57. Novartis Company Information
 Table 58. Novartis Introduction and Business Overview
 Table 59. Novartis Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 60. Novartis Microsphere Injection Product Offerings
 Table 61. Novartis Recent Developments
 Table 62. Ferring Company Information
 Table 63. Ferring Introduction and Business Overview
 Table 64. Ferring Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 65. Ferring Microsphere Injection Product Offerings
 Table 66. Ferring Recent Developments
 Table 67. Ipsen Company Information
 Table 68. Ipsen Introduction and Business Overview
 Table 69. Ipsen Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 70. Ipsen Microsphere Injection Product Offerings
 Table 71. Ipsen Recent Developments
 Table 72. Takeda Company Information
 Table 73. Takeda Introduction and Business Overview
 Table 74. Takeda Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 75. Takeda Microsphere Injection Product Offerings
 Table 76. Takeda Recent Developments
 Table 77. Roche Company Information
 Table 78. Roche Introduction and Business Overview
 Table 79. Roche Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 80. Roche Microsphere Injection Product Offerings
 Table 81. Roche Recent Developments
 Table 82. AstraZeneca Company Information
 Table 83. AstraZeneca Introduction and Business Overview
 Table 84. AstraZeneca Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 85. AstraZeneca Microsphere Injection Product Offerings
 Table 86. AstraZeneca Recent Developments
 Table 87. OraPharma Company Information
 Table 88. OraPharma Introduction and Business Overview
 Table 89. OraPharma Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 90. OraPharma Microsphere Injection Product Offerings
 Table 91. OraPharma Recent Developments
 Table 92. Alkermes Company Information
 Table 93. Alkermes Introduction and Business Overview
 Table 94. Alkermes Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 95. Alkermes Microsphere Injection Product Offerings
 Table 96. Alkermes Recent Developments
 Table 97. Pacira BioSciences Company Information
 Table 98. Pacira BioSciences Introduction and Business Overview
 Table 99. Pacira BioSciences Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 100. Pacira BioSciences Microsphere Injection Product Offerings
 Table 101. Pacira BioSciences Recent Developments
 Table 102. Xian Janssen Pharmaceutical Company Information
 Table 103. Xian Janssen Pharmaceutical Introduction and Business Overview
 Table 104. Xian Janssen Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 105. Xian Janssen Pharmaceutical Microsphere Injection Product Offerings
 Table 106. Xian Janssen Pharmaceutical Recent Developments
 Table 107. Shandong Luye Pharmaceutical Company Information
 Table 108. Shandong Luye Pharmaceutical Introduction and Business Overview
 Table 109. Shandong Luye Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 110. Shandong Luye Pharmaceutical Microsphere Injection Product Offerings
 Table 111. Shandong Luye Pharmaceutical Recent Developments
 Table 112. Livzon Pharmaceutical Company Information
 Table 113. Livzon Pharmaceutical Introduction and Business Overview
 Table 114. Livzon Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 115. Livzon Pharmaceutical Microsphere Injection Product Offerings
 Table 116. Livzon Pharmaceutical Recent Developments
 Table 117. Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
 Table 118. Zhejiang Sundoc Pharmaceutical Science and Tech Introduction and Business Overview
 Table 119. Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 120. Zhejiang Sundoc Pharmaceutical Science and Tech Microsphere Injection Product Offerings
 Table 121. Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments
 Table 122. Beijing Boente Pharmaceutical Company Information
 Table 123. Beijing Boente Pharmaceutical Introduction and Business Overview
 Table 124. Beijing Boente Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 125. Beijing Boente Pharmaceutical Microsphere Injection Product Offerings
 Table 126. Beijing Boente Pharmaceutical Recent Developments
 Table 127. Guangzhou DiQi Pharmaceuticals Company Information
 Table 128. Guangzhou DiQi Pharmaceuticals Introduction and Business Overview
 Table 129. Guangzhou DiQi Pharmaceuticals Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 130. Guangzhou DiQi Pharmaceuticals Microsphere Injection Product Offerings
 Table 131. Guangzhou DiQi Pharmaceuticals Recent Developments
 Table 132. Qilu Pharmaceutical Company Information
 Table 133. Qilu Pharmaceutical Introduction and Business Overview
 Table 134. Qilu Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 135. Qilu Pharmaceutical Microsphere Injection Product Offerings
 Table 136. Qilu Pharmaceutical Recent Developments
 Table 137. Changchun GeneScience Pharmaceutical Company Information
 Table 138. Changchun GeneScience Pharmaceutical Introduction and Business Overview
 Table 139. Changchun GeneScience Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 140. Changchun GeneScience Pharmaceutical Microsphere Injection Product Offerings
 Table 141. Changchun GeneScience Pharmaceutical Recent Developments
 Table 142. Anhui BBCA Biochemical Company Information
 Table 143. Anhui BBCA Biochemical Introduction and Business Overview
 Table 144. Anhui BBCA Biochemical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 145. Anhui BBCA Biochemical Microsphere Injection Product Offerings
 Table 146. Anhui BBCA Biochemical Recent Developments
 Table 147. Yichang Humanwell Pharmaceutical Company Information
 Table 148. Yichang Humanwell Pharmaceutical Introduction and Business Overview
 Table 149. Yichang Humanwell Pharmaceutical Microsphere Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 150. Yichang Humanwell Pharmaceutical Microsphere Injection Product Offerings
 Table 151. Yichang Humanwell Pharmaceutical Recent Developments
 Table 152. Key Raw Materials Lists
 Table 153. Key Suppliers of Raw Materials Lists
 Table 154. Microsphere Injection Downstream Customers
 Table 155. Microsphere Injection Distributors List
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources


List of Figures
 Figure 1. Microsphere Injection Product Picture
 Figure 2. Global Microsphere Injection Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 4. Global Microsphere Injection Sales Volume (K Units), 2021–2032
 Figure 5. Global Microsphere Injection Sales Price (US$/Unit), 2021–2032
 Figure 6. Microsphere Injection Report Years Considered
 Figure 7. Global Microsphere Injection Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Microsphere Injection Sales Volume Ranking of Players (K Units), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Microsphere Injection Revenue in 2025
 Figure 10. Microsphere Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Risperidone Microspheres Picture
 Figure 12. Leuprorelin Microspheres Picture
 Figure 13. Octreotide Microspheres Picture
 Figure 14. Triptorelin Microspheres Picture
 Figure 15. Others Picture
 Figure 16. Global Microsphere Injection Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Microsphere Injection Sales Value Market Share by Type, 2025 & 2032
 Figure 18. Global Microsphere Injection Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
 Figure 19. Global Microsphere Injection Sales Volume Market Share by Type, 2025 & 2032
 Figure 20. Global Microsphere Injection Price by Type (US$/Unit), 2021–2032
 Figure 21. Product Picture of Malignant Tumors
 Figure 22. Product Picture of Diabetes
 Figure 23. Product Picture of Cardiovascular Diseases
 Figure 24. Product Picture of Mental Illness
 Figure 25. Product Picture of Others
 Figure 26. Global Microsphere Injection Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 27. Global Microsphere Injection Sales Value Market Share by Application, 2025 & 2032
 Figure 28. Global Microsphere Injection Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
 Figure 29. Global Microsphere Injection Sales Volume Market Share by Application, 2025 & 2032
 Figure 30. Global Microsphere Injection Price by Application (US$/Unit), 2021–2032
 Figure 31. North America Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 32. North America Microsphere Injection Sales Value by Country (%), 2025 vs 2032
 Figure 33. Europe Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 34. Europe Microsphere Injection Sales Value by Country (%), 2025 vs 2032
 Figure 35. Asia Pacific Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 36. Asia Pacific Microsphere Injection Sales Value by Region (%), 2025 vs 2032
 Figure 37. South America Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 38. South America Microsphere Injection Sales Value by Country (%), 2025 vs 2032
 Figure 39. Middle East & Africa Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 40. Middle East & Africa Microsphere Injection Sales Value by Country (%), 2025 vs 2032
 Figure 41. Key Countries/Regions Microsphere Injection Sales Value (%), 2021–2032
 Figure 42. Key Countries/Regions Microsphere Injection Sales Volume (%), 2021–2032
 Figure 43. United States Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 44. United States Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 45. United States Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 46. Europe Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 47. Europe Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 48. Europe Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 49. China Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 50. China Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 51. China Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 52. Japan Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 53. Japan Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 54. Japan Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 55. South Korea Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 56. South Korea Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 57. South Korea Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 58. Southeast Asia Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 59. Southeast Asia Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 60. Southeast Asia Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 61. India Microsphere Injection Sales Value (US$ Million), 2021–2032
 Figure 62. India Microsphere Injection Sales Value by Type (%), 2025 vs 2032
 Figure 63. India Microsphere Injection Sales Value by Application (%), 2025 vs 2032
 Figure 64. Microsphere Injection Industrial Chain
 Figure 65. Microsphere Injection Manufacturing Cost Structure
 Figure 66. Channels of Distribution (Direct Sales, and Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed

Description

The global market for Microsphere Injection was estimated to be worth US$ 209 million in 2025 and is projected to reach US$ 302 million, growing at a CAGR of 5.5% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Microsphere Injection cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

The Asia-Pacific market for Microsphere Injection was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Microsphere Injection was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

Market Segmentation

Related Reports

Microsphere Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microsphere Injection was estimated to be worth US$ 196 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 149
USD 3950.00
(Single User License)
Global Microsphere Injection Market Insights, Forecast to 2031
The global Microsphere Injection market is projected to grow from US$ 209 million in 2025 to US$ 288 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Published: 2025-04-16
Pages: 180
USD 4900.00
(Single User License)
Global Microsphere Injection Market Research Report 2025
The global market for Microsphere Injection was valued at US$ 196 million in the year 2024 and is projected to reach a revised size of US$ 288 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-04-16
Pages: 99
USD 2900.00
(Single User License)
Global Microsphere Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microsphere Injection market size was US$ 196 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 106
USD 4250.00
(Single User License)
Global Microsphere Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microsphere Injection market size was US$ 209 million in 2025 and is forecast to reach a readjusted size of US$ 302 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 105
USD 4250.00
(Single User License)
Global Microsphere Injection Market Research Report 2026
The global Microsphere Injection market was valued at US$ 209 million in 2025 and is anticipated to reach US$ 302 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 132
USD 2900.00
(Single User License)
Global Microsphere Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microsphere Injection market is projected to grow from US$ 209 million in 2025 to US$ 302 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 177
USD 4900.00
(Single User License)

Microsphere Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microsphere Injection was estimated to be worth US$ 196 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 149
USD 3950.00 (Single User License)
Global Microsphere Injection Market Insights, Forecast to 2031
The global Microsphere Injection market is projected to grow from US$ 209 million in 2025 to US$ 288 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
Published: 2025-04-16
Pages: 180
USD 4900.00 (Single User License)
Global Microsphere Injection Market Research Report 2025
The global market for Microsphere Injection was valued at US$ 196 million in the year 2024 and is projected to reach a revised size of US$ 288 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-04-16
Pages: 99
USD 2900.00 (Single User License)
Global Microsphere Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microsphere Injection market size was US$ 196 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 106
USD 4250.00 (Single User License)
Global Microsphere Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microsphere Injection market size was US$ 209 million in 2025 and is forecast to reach a readjusted size of US$ 302 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 105
USD 4250.00 (Single User License)
Global Microsphere Injection Market Research Report 2026
The global Microsphere Injection market was valued at US$ 209 million in 2025 and is anticipated to reach US$ 302 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-03-11
Pages: 132
USD 2900.00 (Single User License)
Global Microsphere Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microsphere Injection market is projected to grow from US$ 209 million in 2025 to US$ 302 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 177
USD 4900.00 (Single User License)